東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Generating CRISPR-Cas9 genome-engine...

McManus, Sean J.

FindBook

Google Book

Amazon

博客來

Generating CRISPR-Cas9 genome-engineered human embryonic stem cells to model a genetic mechanism of asthma.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Generating CRISPR-Cas9 genome-engineered human embryonic stem cells to model a genetic mechanism of asthma./
作者:	McManus, Sean J.
面頁冊數:	57 p.
附註:	Source: Masters Abstracts International, Volume: 54-05.
Contained By:	Masters Abstracts International54-05(E).
標題:	Genetics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1591792
ISBN:	9781321837445

Generating CRISPR-Cas9 genome-engineered human embryonic stem cells to model a genetic mechanism of asthma.
McManus, Sean J.

Generating CRISPR-Cas9 genome-engineered human embryonic stem cells to model a genetic mechanism of asthma. - 57 p.

Source: Masters Abstracts International, Volume: 54-05.

Thesis (M.S.)--Boston University, 2015.

This item must not be sold to any third party vendors.

Asthma is a major public health epidemic that presents a heavy burden on those who suffer from the disease. Little is currently understood about the genetic signature that distinguishes one type of asthma from another. Recently, the single nucleotide polymorphism (SNP) rs968567 was found to have a high degree of association in asthmatic patients (Sharma et al., 2014). This particular SNP is in the promoter region of the FADS2 gene that synthesizes the enzyme delta-6-desaturase (D6D). D6D mediates the formation of pro-inflammatory factors that lead to exacerbation of asthmatic symptoms. We engineered a novel, customized CRISPR-Cas9 construct to induce the SNP rs968567 in the HUES9 human embryonic stem cell (hESC) line. Our results show success in generating the custom CRISPR-Cas9 construct for use in stem cells, while efficiency in expressing the desired mutation in our cell line is currently being optimized. Disease modeling in the genomic era of medicine provides an opportunity for the development of personalized medical treatment. Future projects aim to differentiate stem cell lines edited with our CRISPR-Cas9 construct to lung progenitor cells to study the cellular phenotype of this mutation in context of asthma pathogenesis.

ISBN: 9781321837445Subjects--Topical Terms:

530508
Genetics.

Generating CRISPR-Cas9 genome-engineered human embryonic stem cells to model a genetic mechanism of asthma.
LDR:02225nmm a2200301 4500 001 2066451
005 20151106144900.5
008 170521s2015 ||||||||||||||||| ||eng d
020 $a 9781321837445
035 $a (MiAaPQ)AAI1591792
035 $a AAI1591792
040 $a MiAaPQ $c MiAaPQ
100 1 $a McManus, Sean J. $3 3181248
245 1 0 $a Generating CRISPR-Cas9 genome-engineered human embryonic stem cells to model a genetic mechanism of asthma.
300 $a 57 p.
500 $a Source: Masters Abstracts International, Volume: 54-05.
500 $a Advisers: Jean L. Spencer; Paul H. Lerou.
502 $a Thesis (M.S.)--Boston University, 2015.
506 $a This item must not be sold to any third party vendors.
520 $a Asthma is a major public health epidemic that presents a heavy burden on those who suffer from the disease. Little is currently understood about the genetic signature that distinguishes one type of asthma from another. Recently, the single nucleotide polymorphism (SNP) rs968567 was found to have a high degree of association in asthmatic patients (Sharma et al., 2014). This particular SNP is in the promoter region of the FADS2 gene that synthesizes the enzyme delta-6-desaturase (D6D). D6D mediates the formation of pro-inflammatory factors that lead to exacerbation of asthmatic symptoms. We engineered a novel, customized CRISPR-Cas9 construct to induce the SNP rs968567 in the HUES9 human embryonic stem cell (hESC) line. Our results show success in generating the custom CRISPR-Cas9 construct for use in stem cells, while efficiency in expressing the desired mutation in our cell line is currently being optimized. Disease modeling in the genomic era of medicine provides an opportunity for the development of personalized medical treatment. Future projects aim to differentiate stem cell lines edited with our CRISPR-Cas9 construct to lung progenitor cells to study the cellular phenotype of this mutation in context of asthma pathogenesis.
590 $a School code: 0017.
650 4 $a Genetics. $3 530508
650 4 $a Cellular biology. $3 3172791
650 4 $a Molecular biology. $3 517296
690 $a 0369
690 $a 0379
690 $a 0307
710 2 $a Boston University. $b Medical Sciences GMS. $3 2103826
773 0 $t Masters Abstracts International $g 54-05(E).
790 $a 0017
791 $a M.S.
792 $a 2015
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1591792